Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma

NCT03276832 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Melanoma
Stage IIIB Cutaneous Melanoma AJCC v7
Stage IIIC Cutaneous Melanoma AJCC v7
Stage IV Cutaneous Melanoma AJCC v6 and v7

Interventions

DRUG: Imiquimod
PROCEDURE: Biopsy
BIOLOGICAL: Pembrolizumab
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Magnetic Resonance Imaging

Sponsor

Mayo Clinic